Increased levels of inflammatory cytokines, such as interferon-γ, IL-1β, and TNF-α, commonly seen in CKD, may lead to a decreased sensitivity of erythroid progenitors to EPO [92,93,94,95]. This evidence concerns the gene EPO and chronic kidney disease.